PharmaShots Weekly Snapshots (August 15 - 19, 2022)
Published: Aug 19, 2022 | Tags: IASO Biotherapeutics, Equecabtagene Autoleucel, Neuromyelitis Optica Spectrum Disorder, Regulatory, NMPA, IND, Approval
Published: Aug 19, 2022 | Tags: IMPACT Therapeutics, IMP4297, Temozolomide, Small Cell Lung Cancer, Regulatory, US, FDA, Orphan Drug Designation
Published: Aug 19, 2022 | Tags: Menarini, Elacestrant, ER+/HER2- Advanced, Metastatic Breast Cancer, Regulatory, EMA, MAA
Published: Aug 19, 2022 | Tags: Aeglea BioTherapeutics, Pegzilarginase, Arginase 1 Deficiency, Regulatory, EMA, MAA
Published: Aug 19, 2022 | Tags: Agios, Pyrukynd, mitapivat, Pyruvate Kinase Deficiency, P-III (ACTIVATE-T) Study, Lancet Haematology
Published: Aug 19, 2022 | Tags: Jazz, Epidiolex, Epidyolex, cannabidiol, Epilepsy, Myoclonic-Atonic Seizures, P-III GWEP20238 Trial
Published: Aug 18, 2022 | Tags: CSL Vifor, Tavneos, avacopan, Anca-Associated Vasculitis, GPA, MPA, NICE, Regulatory
Published: Aug 18, 2022 | Tags: Genentech, Jemincare, JMKX002992, Prostate Cancer, Pharma
Published: Aug 18, 2022 | Tags: Blueprint Medicines, Ayvakit, avapritinib, Non-Advanced Systemic Mastocytosis, Clinical trial, PIONEER Trial
GSK Reports the US FDA’s Acceptance of NDA for Momelotinib to Treat Myelofibrosis
Published: Aug 18, 2022 | Tags: GSK, Momelotinib, Myelofibrosis, Regulatory, US, FDA, Acceptance, NDA
Published: Aug 18, 2022 | Tags: bluebird bio, Zynteglo, Beta-Thalassemia, Regulatory, US, FDA, Approval
Published: Aug 18, 2022 | Tags: Sanofi, Atomwise, AI-Powered Drug Discovery, Pharma, AtomNet platform
Published: Aug 17, 2022 | Tags: Samsung Bioepis, Organon, Hadlima, biosimilar, adalimumab, Chronic Autoimmune Diseases Regulatory, US, FDA, Approval
Published: Aug 17, 2022 | Tags: Tessa, TT11, Classical Hodgkin Lymphoma, Clinical Trial, P-Ib Trial
Chugai and Towa’s Edirol Receive the MHLW Approval for the Treatment of Osteoporosis
Published: Aug 17, 2022 | Tags: Chugai, Towa, Edirol, Osteoporosis, Regulatory, MHLW, Approval
Published: Aug 17, 2022 | Tags: Sanofi, Amcenestrant, ER+/HER2- Advanced Breast Cancer, Clinical Trial, P-III AMEERA-5 Trial
Published: Aug 17, 2022 | Tags: Tris Pharma, Dyanavel XR, amphetamine, Attention Deficit Hyperactivity Disorder, Regulatory, Journal of Clinical Psychiatry
Published: Aug 17, 2022 | Tags: Medison, Albireo, Odevixibat, Cholestatic Liver Diseases, Pharma, Canada, Israel
Published: Aug 16, 2022 | Tags: Merck, Orna Therapeutics, RNA Therapies, Infectious Disease, Oncology, Biotech, oRNA-LNP technology platform
Published: Aug 16, 2022 | Tags: Genentech, Polivy, polatuzumab vedotin-piiq, Diffuse Large B-Cell Lymphoma, Regulatory, US FDA, sBLA
Published: Aug 16, 2022 | Tags: Guardant Health, Guardant Reveal Liquid Biopsy Test, MedTech, Breast, Lung Cancers
Published: Aug 16, 2022 | Tags: Gilead, Trodelvy, sacituzumab govitecan-hziy, HR+/HER2- Metastatic Breast Cancer, Clinical Trials, P-III TROPiCS-02 Study
Published: Aug 16, 2022 | Tags: Horizon, Q32 Bio, ADX-914, Autoimmune Diseases, Pharma
Published: Aug 16, 2022 | Tags: Gilead, Everest, Trodelvy, sacituzumab govitecan, Metastatic Triple-Negative Breast Cancer, Asia
Related Post: PharmaShots Weekly Snapshots (August 8 - 12, 2022)
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.